Commitments (Details Narrative) $ in Thousands |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Oct. 18, 2023
shares
|
Nov. 30, 2025
USD ($)
ft²
|
Dec. 31, 2025
USD ($)
|
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Square feet | ft² | 19,594 | ||
| Lease option to extend | The lease term will commence on April 1, 2026 and is 62 months with two options to extend the lease term for five years each. The Company also has a one-time option to terminate the lease at the end of the third year, provided certain conditions are met. | ||
| Lease description | The initial annual lease payment is $0.3 million and increases by 3.5% on an annual basis, resulting in total undiscounted future minimum lease payments of $1.5 million over the initial 62-month term. | ||
| Initial annual lease payment | $ 300 | ||
| Undiscounted future minimum lease | $ 1,500 | $ 20 | |
| Lease term | 62 months | ||
| Non-cancelable contractual commitment | $ 5,500 | ||
| Registration rights | the Company is required to make pro rata payments to each holder as liquidated damages in an amount equal to 1.0% of the aggregate amount paid pursuant to the Securities Purchase Agreement by such investor for each 30-day period or pro rata for any portion thereof during which such event continues, provided that the maximum liquidated damages shall not exceed 6.0% of the aggregate amount invested by each such holder in the registrable securities. | ||
| Securities Purchase Agreement [Member] | |||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Issuance of common stock shares to Pfizer pursuant to an Equity Grant Agreement | shares | 5,747,787 |